Ardent Health Inc. Common Stock (NYSE: ARDT)
24 Days left to seek lead plaintiff status.
The complaint alleges on November 12, 2025, after market hours, Ardent Health revealed a $43 million decrease in third quarter 2025 revenue. The decrease resulted from revised determinations of accounts receivable collectability after the Company transitioned to a new revenue accounting system and from purported “recently completed hindsight evaluations of historical collection trends.” Ardent Health also announced a cut to 2025 EBITDA guidance of $57.5 million at the midpoint, or about 9.6%, from $575 million – $625 million to $530 million – $555 million because of “persistent industry-wide cost pressures,” including “payer denials.” On this news, the price of Ardent Health stock fell $4.75 per share, or nearly 34%, from $14.05 per share on November 12, 2025, to close at $9.30 per share on November 13, 2025, on unusually heavy trading volume.